AI-driven Structure-enabled Antiviral Platform (ASAP)

ASAP uses artificial intelligence and computational chemistry to accelerate structure-based open science antiviral drug discovery and deliver oral antivirals for pandemics with the goal of global, equitable, and affordable access.

ASAP is organized into a series of successive stages of the drug discovery pipeline.